<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">465739709</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323111805.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170327e19901101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF02368454</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF02368454</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">Tallarida</subfield>
   <subfield code="D">Ronald</subfield>
   <subfield code="u">Department of Pharmacology, Temple University School of Medicine, 19140, Philadelphia, PA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
   <subfield code="a">Further characterization of a control model for ligand-receptor interaction: Phase plane geometry, stability, and oscillation</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Ronald Tallarida]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The local concentration of an endogenous ligand that binds to a specific cellular receptor according to the mass-action law is controlled. The ligand concentration (z) remains bounded in an interval that contains the basal point. The current study is a more detailed examination of a control model that we previously proposed in which the feedback is a function (Φ) of the concentration (y) of the receptor-bound ligand. Previously we showed that if Φ′ (y)≤0 at a critical point then that point is stable Accordingly, at an unstable critical point Φ′ (y)&gt;0. We now show that if Φ(y) is continous in [y1, y2], where y1 and y2 are adjacent critical points, and if Φ′ (y1)≤0 then the critical point at y2 is unstable. The distance between these adjacent critical points is crucial for maintaining control in response to a dose (or release) of ligand. It is further shown that the difference in the slopes of the binding and control curves at their intersection on the phase-plane portrait is an indicator of stability and of the characteristic frequency of oscillation in the system. Together these findings provide new insights needed in the modelling of specific ligand-receptor interactions.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Pergamon Press plc, 1990</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Ligand-receptor interaction</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Control</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Stability</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Oscillation</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Mass-action law</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Annals of Biomedical Engineering</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">18/6(1990-11-01), 671-684</subfield>
   <subfield code="x">0090-6964</subfield>
   <subfield code="q">18:6&lt;671</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">18</subfield>
   <subfield code="o">10439</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF02368454</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF02368454</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">100</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Tallarida</subfield>
   <subfield code="D">Ronald</subfield>
   <subfield code="u">Department of Pharmacology, Temple University School of Medicine, 19140, Philadelphia, PA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Annals of Biomedical Engineering</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">18/6(1990-11-01), 671-684</subfield>
   <subfield code="x">0090-6964</subfield>
   <subfield code="q">18:6&lt;671</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">18</subfield>
   <subfield code="o">10439</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
